Heart failure patients who have early follow-up with general medicine or cardiology providers within 7 days of discharge from the hospital had 19% had lower odds of readmission within 30 days.
Heart failure patients who have early follow-up with general medicine or cardiology providers within 7 days of discharge from the hospital had 19% had lower odds of readmission within 30 days, a new study from Kaiser Permanente physicians suggests. The study, published in Medical Care, followed 11,985 patients at a large, integrated healthcare delivery system in Northern California from January 2006 through June 2013. Heart failure poses a substantial health and economic burden nationally and is expected to grow significantly in the future, the authors note.
The patients were adults with a primary diagnosis of heart failure. All were discharged to home without hospice care. There were 1587 cases of patients being readmitted to the hospital within the first 30 days after discharge who were matched with 7935 patients who were not readmitted to the hospital within 30 days. Follow-up care was defined as outpatient visits and telephone calls with cardiology and general medicine providers in nonemergency and nonurgent care settings.
After adjusting for differences in patient sociodemographic and clinical characteristics, acute severity of illness, hospitalization characteristics, and postdischarge medication changes and lab testing, the researchers found that early initial outpatient contact within 7 days of discharge was associated with lower odds of readmission to hospitals within 30 days. Later outpatient contact, between 8 and 30 days after discharge, was not significantly associated with readmission.
Initial contact with patients by telephone was associated with lower adjusted odds of 30-day readmission, but the difference was not significant. Although all clinic visits were with physicians, the researchers said it was important to note that 45% of the follow-up telephone calls were made by nonphysician providers who were trained to follow an outpatient heart failure treatment protocol.
“Our study showed that the timing of follow-up after hospitalization for heart failure is an important factor,” said lead author Keane K. Lee, MD, MS, a cardiologist and research scientist with Kaiser Permanente. “Early follow-up within seven days, even with a telephone call, was associated with lower risk of readmission, whereas follow-up after seven days was not associated with this benefit.”
The study authors said their findings suggest that clinicians may be able to reduce hospital readmissions in high-risk patients by improving transitional care and making use of the increasing integration occurring in the healthcare system today, which includes electronic medical records and a coordinated approach to care among all types of providers across inpatient and outpatient settings.
Racial, Ethnic Disparities May Impact Age Differences at First Heart Failure Hospitalization
September 4th 2025Social determinants of health were associated with a younger age of first hospitalization for heart failure in Black and Hispanic patients when compared with Asian and White patients.
Read More
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
Patients With HFpEF May Benefit From Accelerated Cardiac Pacing
August 28th 2025In an observational extension of the myPACE clinical trial, researchers found that a personalized accelerated pacing in patients with heart failure with preserved ejection fraction (HFpEF) and a preexisting physiological pacer saw a slower trend in adverse cardiac events and overall improved health status.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Finerenone Demonstrates Safety and Efficacy in Heart Failure When Combined With Diuretics
August 13th 2025Clinical trial results establish the safety and efficacy of finerenone to help preserve potassium levels and reduce sodium in patients on diuretics with heart failure and mildly reduced ejection fraction or preserved ejection fraction.
Read More
Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation
August 13th 2025The cause of dilated cardiomyopathy (DCM) can be associated with the presence of the TTN gene combined with preexisting comorbidities like atrial fibrillation, which increase the odds of developing DCM.
Read More